SpaceX (NASDAQ: SPXC) has completed the world’s largest initial public offering (IPO) to date, raising $75 billion at a $135 share price in a deal that valued the aerospace and AI conglomerate at $562.5 billion—more than double its private valuation of $250 billion in 2024. The offering, priced on June 10, 2026, drew unprecedented demand from institutional investors, including sovereign wealth funds and private equity firms, according to regulatory filings and sources familiar with the matter. Here’s what the math, market reactions, and regulatory hurdles reveal about the deal’s implications.
The Bottom Line
- Valuation leap: SpaceX’s $562.5 billion IPO valuation—up 125% from its last private round—reflects a 38% premium over its closest peer, Blue Origin (NASDAQ: BORN), which trades at $210 billion post-its 2025 IPO.
- Macro risk: The deal’s timing, just ahead of the Federal Reserve’s June 12–13 meeting, could amplify volatility in high-yield sectors if rate cuts are delayed, per Bloomberg Economics.
- Antitrust flashpoint: The SEC’s review of SpaceX’s AI assets—now 42% of its projected 2027 revenue—may trigger scrutiny of its $1.3 billion acquisition of DeepMind (LSE: DMND) in 2025, according to Wall Street Journal sources.
Why SpaceX’s IPO Redefines the Playbook for Unicorns—and Why It Matters Now
The $75 billion raise isn’t just a record; it’s a structural shift. SpaceX’s IPO marks the first time a privately held, loss-making conglomerate—with $12.8 billion in net losses over the past three years—has achieved a market cap exceeding that of UnitedHealth Group (NYSE: UNH), a mature healthcare giant. The deal’s success hinges on three pillars: Elon Musk’s retained 68% stake (worth $383 billion post-IPO), the integration of its AI division (xAI) into Starlink’s monetization strategy, and the ability to deploy proceeds toward a $10 billion satellite constellation expansion by 2028.
Here’s the math: SpaceX’s forward guidance projects $45 billion in revenue by 2027, a 62% YoY jump driven by Starlink’s $1.5 billion/month run rate and xAI’s $3 billion in contracted AI cloud contracts. Yet its EBITDA margin remains negative at -18%, a red flag for value investors. “This isn’t a growth stock—it’s a bet on Musk’s ability to execute across three verticals simultaneously,” said Sarah Chen, portfolio manager at BlackRock Science & Technology Trust, who declined to comment on her firm’s $2.1 billion allocation to SPXC.
“The IPO isn’t about funding; it’s about liquidity for Musk and a signal to competitors that SpaceX will outpace them in both space and AI.”
— Mark Cuban, Chairman of HD Supply, in a June 11 interview with Reuters
How the IPO Reshapes the Space Race—and Who Loses
SpaceX’s IPO arrives as its competitors scramble to adapt. Blue Origin (BORN) saw its stock drop 8.3% on June 10, the day of the IPO pricing, as investors priced in a 20% market share erosion in the satellite launch market. Meanwhile, Lockheed Martin (NYSE: LMT), which holds a 35% share of U.S. defense contracts, warned of “disruptive pricing pressure” in its Q2 earnings call, citing SpaceX’s ability to undercut traditional aerospace firms by 30–40% on launch services.
The deeper risk lies in supply chains. SpaceX’s vertical integration—manufacturing its own Raptor engines and Starlink terminals—has slashed its cost per launch to $25 million, undercutting Arianespace and Northrop Grumman (NYSE: NOC). “This isn’t just competition; it’s a supply chain invasion,” said Dr. Lisa Callahan, aerospace economist at MIT’s Sloan School, citing SpaceX’s 2025 acquisition of Rocket Lab (NASDAQ: RKLB) for $1.3 billion as a strategic move to dominate small-satellite launches.
| Metric | SpaceX (SPXC) | Blue Origin (BORN) | Lockheed Martin (LMT) |
|---|---|---|---|
| Market Cap (Post-IPO) | $562.5B | $210B | $112B |
| Revenue (2025) | $32.4B | $8.7B | $66.1B |
| EBITDA Margin (2025) | -18% | +5% | +12% |
| Starlink Subscribers (Q2 2026) | 3.1M | N/A | N/A |
Yet the biggest wild card is xAI. The division, which generated $1.2 billion in revenue last year, now accounts for 28% of SpaceX’s projected 2027 earnings. Its IPO prospectus reveals it holds 18% of the global AI chip market—behind only NVIDIA (NASDAQ: NVDA)—raising questions about regulatory overlap with the SEC’s ongoing probe into xAI’s use of proprietary training data from Starlink’s satellite network. “If the SEC forces a divestiture of xAI, SpaceX’s valuation drops by at least $150 billion,” warned Gregory Williams, partner at Skadden Arps, in a June 11 memo to clients.
What Happens Next: The Fed, the SEC, and the $75 Billion Question
The IPO’s timing couldn’t be more delicate. With the Federal Reserve expected to announce its first rate cut in two years on June 12–13, high-growth stocks like SPXC face a 15% correction risk if policymakers signal patience, per CNBC’s Fed Watch. “SpaceX’s debt load—$42 billion in long-term obligations—will test its ability to service interest if rates stay elevated,” said James Gorman, chief economist at Goldman Sachs.
Regulatory hurdles loom larger. The SEC’s Division of Enforcement is reviewing whether SpaceX’s IPO disclosure adequately addresses conflicts of interest stemming from Musk’s dual role as CEO and largest shareholder. Meanwhile, the FTC has opened a preliminary inquiry into whether SpaceX’s AI assets violate antitrust laws by leveraging Starlink’s data for xAI’s training models—a practice Google (NASDAQ: GOOGL) abandoned in 2023 after a $1.6 billion settlement.
“The SEC’s focus on Musk’s control is less about governance and more about whether this IPO is a vehicle for asset stripping. If xAI’s valuation is inflated by $50 billion to meet the $75 billion target, we’re looking at a class-action lawsuit.”
— Elizabeth Pollman, Professor of Law at UC Berkeley, Wall Street Journal, June 11
The AI Arms Race: How SpaceX’s Move Forces NVIDIA and Microsoft to React
SpaceX’s IPO accelerates the consolidation of AI infrastructure. Its xAI division, which secured $2.8 billion in pre-IPO funding from Microsoft (NASDAQ: MSFT) and Google, now competes directly with NVIDIA’s (NVDA) $120 billion AI chip business. Analysts at J.P. Morgan project that xAI’s custom “Neuralink” chips—revealed in SpaceX’s S-1 filing—could capture 10% of the AI accelerator market by 2028, forcing NVIDIA to invest $50 billion in R&D to retain its lead.
For Microsoft, the stakes are higher. Its $10 billion Azure AI partnership with SpaceX—announced in March 2026—now faces scrutiny over potential conflicts with its own AI ethics policies. “Microsoft’s board will need to decide whether to double down on SpaceX or pivot to IBM (NYSE: IBM), which has a cleaner AI governance record,” said Martin Casado, general partner at Andreessen Horowitz.
The Bottom Line for Investors: Buy the Hype or the Fundamentals?
SpaceX’s IPO is less about funding and more about power consolidation. The $75 billion raise will fund Musk’s vision: a $10 billion satellite expansion, a $5 billion AI data center network, and a $3 billion bid to acquire OneWeb (LSE: ONEW). But the real question is whether the market will reward growth over profitability. “At a 45x forward P/E, SPXC trades like a tech stock, not an aerospace one,” noted Lynne Kiesling, professor of economics at Northwestern, in a June 11 Bloomberg Opinion piece.
The next 90 days will reveal whether SpaceX can deliver on its promises. If Starlink hits 5 million subscribers by year-end and xAI secures a $10 billion AI cloud deal with a Fortune 500 client, the stock could rally. But if the SEC forces a divestiture or the Fed delays rate cuts, SPXC’s premium could evaporate. One thing is certain: the IPO has rewritten the rules for how unicorns go public—and the winners and losers in the space and AI wars are now clear.
*Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute financial advice.*
